Loading...

Reist, Christopher

TitleProfessor In Residence
InstitutionUniversity of California, Irvine
DepartmentPsychiatry and Human Behavior
Address1001 Health Sciences Road
CA 92697-3950
Phone(562) 826-5758, 5601
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Raskind MA, Peskind ER, Chow B, Harris C, Davis-Karim A, Holmes HA, Hart KL, McFall M, Mellman TA, Reist C, Romesser J, Rosenheck R, Shih MC, Stein MB, Swift R, Gleason T, Lu Y, Huang GD. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. N Engl J Med. 2018 02 08; 378(6):507-517. PMID: 29414272.
      View in: PubMed
    2. Reist C, Gory A, Hollifield M, Krakow B. Potential benefit of sleep assessment prior to PTSD treatment. Psychiatry Res. 2018 Apr; 262:354-355. PMID: 29074074.
      View in: PubMed
    3. Ramaswamy S, Driscoll D, Reist C, Smith LM, Albers LJ, Rose J, Nguyen L, Monga V, Doria R, Hollifield M. A Double-Blind, Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Posttraumatic Stress Disorder and Comorbid Depression. Prim Care Companion CNS Disord. 2017 Aug 24; 19(4). PMID: 28858440.
      View in: PubMed
    4. Reist C, Mee S, Fujimoto K, Rajani V, Bunney WE, Bunney BG. Assessment of psychological pain in suicidal veterans. PLoS One. 2017; 12(5):e0177974. PMID: 28558020.
      View in: PubMed
    5. Reist C, Gory A, Hollifield M. Sleep-Disordered Breathing Impact on Efficacy of Prolonged Exposure Therapy for Posttraumatic Stress Disorder. J Trauma Stress. 2017 04; 30(2):186-189. PMID: 28273371.
      View in: PubMed
    6. Armstrong NP, Cohen AN, Hellemann G, Reist C, Young AS. Validating a brief version of the Mental Health Recovery Measure for individuals with schizophrenia. Psychiatr Serv. 2014 Sep 01; 65(9):1154-9. PMID: 24828568.
      View in: PubMed
    7. Niv N, Cohen AN, Hamilton A, Reist C, Young AS. Effectiveness of a psychosocial weight management program for individuals with schizophrenia. J Behav Health Serv Res. 2014 Jul; 41(3):370-80. PMID: 22430566; PMCID: PMC3809160.
    8. Hamilton AB, Cohen AN, Glover DL, Whelan F, Chemerinski E, McNagny KP, Mullins D, Reist C, Schubert M, Young AS. Implementation of evidence-based employment services in specialty mental health. Health Serv Res. 2013 Dec; 48(6 Pt 2):2224-44. PMID: 24138608; PMCID: PMC4097836.
    9. Hayama HR, Drumheller KM, Mastromonaco M, Reist C, Cahill LF, Alkire MT. Event-related functional magnetic resonance imaging of a low dose of dexmedetomidine that impairs long-term memory. Anesthesiology. 2012 Nov; 117(5):981-95. PMID: 22929730; PMCID: PMC3482301.
    10. Reist C, Wu JC, Lilja Y, Mukherjee J, Gripeos D, Constantinescu C, Raggi MA, Mercolini L, Ozdemir V. Ketoconazole-associated preferential increase in dopamine D2 receptor occupancy in striatum compared to pituitary in vivo: role for drug transporters? J Clin Psychopharmacol. 2012 Feb; 32(1):110-3. PMID: 22198458.
      View in: PubMed
    11. Mee S, Bunney BG, Bunney WE, Hetrick W, Potkin SG, Reist C. Assessment of psychological pain in major depressive episodes. J Psychiatr Res. 2011 Nov; 45(11):1504-10. PMID: 21831397.
      View in: PubMed
    12. Citrome L, Reist C, Palmer L, Montejano LB, Lenhart G, Cuffel B, Harnett J, Sanders KN. Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder. Schizophr Res. 2009 Dec; 115(2-3):115-20. PMID: 19864113.
      View in: PubMed
    13. Citrome L, Reist C, Palmer L, Montejano L, Lenhart G, Cuffel B, Harnett J, Sanders KN. Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder. Schizophr Res. 2009 Mar; 108(1-3):238-44. PMID: 19106035.
      View in: PubMed
    14. O'Halloran JP, Kemp AS, Gooch KN, Harvey PD, Palmer BW, Reist C, Schneider LS. Psychometric comparison of computerized and standard administration of the neurocognitive assessment instruments selected by the CATIE and MATRICS consortia among patients with schizophrenia. Schizophr Res. 2008 Nov; 106(1):33-41. PMID: 18160262.
      View in: PubMed
    15. Sergi MJ, Green MF, Widmark C, Reist C, Erhart S, Braff DL, Kee KS, Marder SR, Mintz J. Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol. Am J Psychiatry. 2007 Oct; 164(10):1585-92. PMID: 17898351.
      View in: PubMed
    16. Wynn JK, Green MF, Sprock J, Light GA, Widmark C, Reist C, Erhart S, Marder SR, Mintz J, Braff DL. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophr Res. 2007 Sep; 95(1-3):134-42. PMID: 17662577; PMCID: PMC2716219.
    17. Reist C, Ozdemir V, Wang E, Hashemzadeh M, Mee S, Moyzis R. Novelty seeking and the dopamine D4 receptor gene (DRD4) revisited in Asians: haplotype characterization and relevance of the 2-repeat allele. Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 05; 144B(4):453-7. PMID: 17474081.
      View in: PubMed
    18. Ozdemir V, Bertilsson L, Miura J, Carpenter E, Reist C, Harper P, Widén J, Svensson JO, Albers LJ, Kennedy JL, Endrenyi L, Kalow W. CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6-serotonin-dopamine crosstalk revisited. Pharmacogenet Genomics. 2007 May; 17(5):339-47. PMID: 17429316.
      View in: PubMed
    19. Ozdemir V, Williams-Jones B, Graham JE, Preskorn SH, Gripeos D, Glatt SJ, Friis RH, Reist C, Szabo S, Lohr JB, Someya T. Asymmetry in scientific method and limits to cross-disciplinary dialogue: toward a shared language and science policy in pharmacogenomics and human disease genetics. J Investig Med. 2007 Apr; 55(3):130-41. PMID: 17481382.
      View in: PubMed
    20. Reist C, Mintz J, Albers LJ, Jamal MM, Szabo S, Ozdemir V. Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002. J Clin Psychopharmacol. 2007 Feb; 27(1):46-51. PMID: 17224711.
      View in: PubMed
    21. Moeller FG, Schmitz JM, Steinberg JL, Green CM, Reist C, Lai LY, Swann AC, Grabowski J. Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial. Am J Drug Alcohol Abuse. 2007; 33(3):367-78. PMID: 17613964.
      View in: PubMed
    22. Sergi MJ, Rassovsky Y, Widmark C, Reist C, Erhart S, Braff DL, Marder SR, Green MF. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr Res. 2007 Feb; 90(1-3):316-24. PMID: 17141477.
      View in: PubMed
    23. Ozdemir V, Williams-Jones B, Glatt SJ, Tsuang MT, Lohr JB, Reist C. Shifting emphasis from pharmacogenomics to theragnostics. Nat Biotechnol. 2006 Aug; 24(8):942-6. PMID: 16900136.
      View in: PubMed
    24. Mee S, Bunney BG, Reist C, Potkin SG, Bunney WE. Psychological pain: a review of evidence. J Psychiatr Res. 2006 Dec; 40(8):680-90. PMID: 16725157.
      View in: PubMed
    25. Ozdemir V, Aklillu E, Mee S, Bertilsson L, Albers LJ, Graham JE, Caligiuri M, Lohr JB, Reist C. Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines. Expert Opin Pharmacother. 2006 Feb; 7(2):119-33. PMID: 16433578.
      View in: PubMed
    26. Albers LJ, Ozdemir V, Marder SR, Raggi MA, Aravagiri M, Endrenyi L, Reist C. Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy. J Clin Psychopharmacol. 2005 Apr; 25(2):170-4. PMID: 15738749.
      View in: PubMed
    27. Swann AC, Geller B, Post RM, Altshuler L, Chang KD, Delbello MP, Reist C, Juster IA. Practical Clues to Early Recognition of Bipolar Disorder: A Primary Care Approach. Prim Care Companion J Clin Psychiatry. 2005; 7(1):15-21. PMID: 15841189.
      View in: PubMed
    28. Reist C, Mazzanti C, Vu R, Fujimoto K, Goldman D. Inter-relationships of intermediate phenotypes for serotonin function, impulsivity, and a 5-HT2A candidate allele: His452Tyr. Mol Psychiatry. 2004 Sep; 9(9):871-8. PMID: 15037867.
      View in: PubMed
    29. Sokolski KN, Denson TF, Lee RT, Reist C. Quetiapine for treatment of refractory symptoms of combat-related post-traumatic stress disorder. Mil Med. 2003 Jun; 168(6):486-9. PMID: 12834142.
      View in: PubMed
    30. Reist C, Nakamura K, Sagart E, Sokolski KN, Fujimoto KA. Impulsive aggressive behavior: open-label treatment with citalopram. J Clin Psychiatry. 2003 Jan; 64(1):81-5. PMID: 12590628.
      View in: PubMed
    31. Reist C, Duffy JG, Fujimoto K, Cahill L. beta-Adrenergic blockade and emotional memory in PTSD. Int J Neuropsychopharmacol. 2001 Dec; 4(4):377-83. PMID: 11806863.
      View in: PubMed
    32. Reist C, Mazzanti C, Vu R, Tran D, Goldman D. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. Am J Med Genet. 2001 May 08; 105(4):363-8. PMID: 11378851.
      View in: PubMed
    33. Reist C, Vu R, Coccaro EF, Fujimoto K. Serotonin-stimulated calcium release is decreased in platelets from high impulsivity patients. Int J Neuropsychopharmacol. 2000 Dec; 3(4):315-320. PMID: 11343610.
      View in: PubMed
    Christopher's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _